explodingHeart
Member

The Ozempocalypse Is Nigh
Sorry, you can only get drugs when there's a drug shortage.

tldr; summary:
For three years, a loophole let compounding pharmacies sell cheap GLP-1 weight-loss drugs, but the FDA is shutting it down—banning tirzepatide on March 19 and semaglutide on April 22. Some pharmacies are attempting legal workarounds, but these are unlikely to hold.
In response, pharma giants like Novo Nordisk and Eli Lilly now offer direct sales at $500/month, still costly but cheaper than retail. Patients are stockpiling or even mixing their own drugs, despite risks. The mood on GLP-1 user subreddits is grim but defiant, as many scramble for alternatives in the face of rising costs.